ID   LND1
AC   CVCL_J076
DR   cancercelllines; CVCL_J076
DR   Cosmic; 2051679
DR   Wikidata; Q54902854
RX   PubMed=23489693;
RX   PubMed=25623468;
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Unspecified (PubMed=23489693).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
RX   PubMed=23489693;
RA   Zanna P., Maida I., Grieco C., Guida S., Turpin Sevilla M.C.,
RA   De Summa S., Tommasi S., Vena G.A., Filotico R., Guida G.;
RT   "Three novel human sporadic melanoma cell lines: signaling pathways
RT   controlled by MC1R, BRAF and beta-catenins.";
RL   J. Biol. Regul. Homeost. Agents 27:131-141(2013).
//
RX   PubMed=25623468; DOI=10.1186/s12967-015-0385-4; PMCID=PMC4314759;
RA   Porcelli L., Guida G., Quatrale A.E., Cocco T., Sidella L., Maida I.,
RA   Iacobazzi R.M., Ferretta A., Stolfa D.A., Strippoli S., Guida S.,
RA   Tommasi S., Guida M., Azzariti A.;
RT   "Aurora kinase B inhibition reduces the proliferation of metastatic
RT   melanoma cells and enhances the response to chemotherapy.";
RL   J. Transl. Med. 13:26.1-26.13(2015).
//